This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for people with multiple sclerosis by promoting prompt and effective symptom management and relapse treatment, and comprehensive reviews.
NICE has also produced technology ...
Multiple Sclerosis/therapy,
Multiple Sclerosis/diagnosis,
Ataxia/therapy,
Selective Serotonin Reuptake Inhibitors/therapeutic use,
Fatigue/therapy,
Multiple Sclerosis/rehabilitation,
Fatigue/drug therapy,
Mobility Limitation,
Muscle Spasticity/drug therapy,
Dystonia/drug therapy,
Tremor/drug therapy
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management, comprehensive reviews and effective relapse treatment....
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It
aims to improve the quality of life for adults with multiple sclerosis by promoting symptom
management, comprehensive reviews and effective relapse treatment...
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management, comprehensive reviews and effective relapse treatment. This guideline includes recommendations on: diagno...
Objetivos: aportar recomendaciones a los profesionales de salud sobre el manejo de estos pacientes, basadas en la mejor evidencia científica disponible; Mejorar la calidad del proceso terapéutico de los pacientes portadores de EM; Mejorar la calidad de vida de pacientes con EM; Disminuir la variabilida...
Elaborar una guía de practica clínica (GPC) para orientar a los profesionales sanitarios en la toma de decisiones y disminuir la variabilidad en la atención a las personas con Esclerosis múltiple (EM). Proporcionar información útil para los pacientes, familiares y cuidadores que les permita conocer...
Multiple Sclerosis/therapy,
Multiple Sclerosis/diagnostic imaging,
Multiple Sclerosis/drug therapy,
Magnetic Resonance Spectroscopy/methods,
Interferon-beta/therapeutic use,
Glatiramer Acetate/therapeutic use,
Azathioprine/therapeutic use,
Natalizumab/therapeutic use,
Fingolimod Hydrochloride/therapeutic use,
Mitoxantrone/therapeutic use,
Methotrexate/therapeutic use,
Cyclophosphamide/therapeutic use,
Hematopoietic Stem Cell Transplantation,
Adrenal Cortex Hormones/therapeutic use
